Literature DB >> 16227217

Vaccinia virus intracellular enveloped virions move to the cell periphery on microtubules in the absence of the A36R protein.

Esteban Herrero-Martínez1, Kim L Roberts1, Michael Hollinshead1, Geoffrey L Smith1.   

Abstract

Vaccinia virus (VACV) intracellular enveloped virus (IEV) particles are transported to the cell periphery on microtubules where they fuse with the plasma membrane to form cell-associated enveloped virus (CEV). Two IEV-specific proteins, F12L and A36R, are implicated in mediating transport of IEV. Without F12L, virus morphogenesis halts after formation of IEV, and CEV is not formed, whereas without A36R, IEV was reported not to be transported, yet CEV was formed, To address the roles of A36R and F12L in IEV transport, viruses with deletions of either F12L (vdeltaF12L) or A36R (vdeltaA36R) were labelled with enhanced green fluorescent protein (EGFP) fused to the core protein A5L, and used to follow CEV production with time. Without F12L, CEV production was inhibited by >99 %, whereas without A36R, CEV were produced at approximately 60 % of wild-type levels at 24 h post-infection. Depolymerization of microtubules, but not actin, inhibited CEV formation in vdeltaA36R-infected cells. Moreover, vdeltaA36R IEV labelled with EGFP fused to the B5R protein co-localized with microtubules, showing that the A36R protein is not required for the interaction of IEV with microtubules. Time-lapse confocal microscopy confirmed that both wild-type and vdeltaA36R IEV moved in a stop-start manner at speeds consistent with microtubular movement, although the mean length of vdeltaA36R IEV movement was shorter. These data demonstrate that VACV IEV is transported to the cell surface using microtubules in the absence of A36R, and therefore IEV must attach to microtubule motors using at least one protein other than A36R.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16227217     DOI: 10.1099/vir.0.81260-0

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  23 in total

Review 1.  Virus trafficking - learning from single-virus tracking.

Authors:  Boerries Brandenburg; Xiaowei Zhuang
Journal:  Nat Rev Microbiol       Date:  2007-03       Impact factor: 60.633

2.  Loss of cytoskeletal transport during egress critically attenuates ectromelia virus infection in vivo.

Authors:  Helena Lynn; Jacquelyn Horsington; Lee Kuan Ter; Shuyi Han; Yee Lian Chew; Russell J Diefenbach; Michael Way; Geeta Chaudhri; Gunasegaran Karupiah; Timothy P Newsome
Journal:  J Virol       Date:  2012-04-24       Impact factor: 5.103

3.  Live-cell imaging of Marburg virus-infected cells uncovers actin-dependent transport of nucleocapsids over long distances.

Authors:  Gordian Schudt; Larissa Kolesnikova; Olga Dolnik; Beate Sodeik; Stephan Becker
Journal:  Proc Natl Acad Sci U S A       Date:  2013-08-12       Impact factor: 11.205

4.  Microtubule disruption synergizes with oncolytic virotherapy by inhibiting interferon translation and potentiating bystander killing.

Authors:  Rozanne Arulanandam; Cory Batenchuk; Oliver Varette; Chadi Zakaria; Vanessa Garcia; Nicole E Forbes; Colin Davis; Ramya Krishnan; Raunak Karmacharya; Julie Cox; Anisha Sinha; Andrew Babawy; Katherine Waite; Erica Weinstein; Theresa Falls; Andrew Chen; Jeff Hamill; Naomi De Silva; David P Conrad; Harold Atkins; Kenneth Garson; Carolina Ilkow; Mads Kærn; Barbara Vanderhyden; Nahum Sonenberg; Tommy Alain; Fabrice Le Boeuf; John C Bell; Jean-Simon Diallo
Journal:  Nat Commun       Date:  2015-03-30       Impact factor: 14.919

5.  Retrograde Transport from Early Endosomes to the trans-Golgi Network Enables Membrane Wrapping and Egress of Vaccinia Virus Virions.

Authors:  Gilad Sivan; Andrea S Weisberg; Jeffrey L Americo; Bernard Moss
Journal:  J Virol       Date:  2016-09-12       Impact factor: 5.103

Review 6.  A guide to viral inclusions, membrane rearrangements, factories, and viroplasm produced during virus replication.

Authors:  Christopher Netherton; Katy Moffat; Elizabeth Brooks; Thomas Wileman
Journal:  Adv Virus Res       Date:  2007       Impact factor: 9.937

7.  Vaccinia virus E2L null mutants exhibit a major reduction in extracellular virion formation and virus spread.

Authors:  Arban Domi; Andrea S Weisberg; Bernard Moss
Journal:  J Virol       Date:  2008-02-20       Impact factor: 5.103

8.  Vaccinia protein F12 has structural similarity to kinesin light chain and contains a motor binding motif required for virion export.

Authors:  Gareth W Morgan; Michael Hollinshead; Brian J Ferguson; Brendan J Murphy; David C J Carpentier; Geoffrey L Smith
Journal:  PLoS Pathog       Date:  2010-02-26       Impact factor: 6.823

9.  Acidic residues in the membrane-proximal stalk region of vaccinia virus protein B5 are required for glycosaminoglycan-mediated disruption of the extracellular enveloped virus outer membrane.

Authors:  Kim L Roberts; Adrien Breiman; Gemma C Carter; Helen A Ewles; Michael Hollinshead; Mansun Law; Geoffrey L Smith
Journal:  J Gen Virol       Date:  2009-03-04       Impact factor: 3.891

10.  Development of smallpox vaccine candidates with integrated interleukin-15 that demonstrate superior immunogenicity, efficacy, and safety in mice.

Authors:  Liyanage P Perera; Thomas A Waldmann; Joseph D Mosca; Nicole Baldwin; Jay A Berzofsky; SangKon Oh
Journal:  J Virol       Date:  2007-06-06       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.